Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

624
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
624
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.7K
Overview
69.7K
Tissue Transplantation01:24

Tissue Transplantation

460
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
460

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma.

Oncoimmunology·2026
Same author

Injectable Cryopreservable Alginate-Gelatin Microbeads for Pro-Angiogenic Cell Therapy.

ACS biomaterials science & engineering·2025
Same author

Injectable, cryopreservable mesenchymal stromal cell-loaded microbeads for pro-angiogenic therapy:<i>in vitro</i>proof-of-concept.

Biomedical materials (Bristol, England)·2024
Same author

Advances in the Regulation of Periostin for Osteoarthritic Cartilage Repair Applications.

Biomolecules·2024
Same author

How to Design Catechol-Containing Hydrogels for Cell Encapsulation Despite Catechol Toxicity.

ACS applied bio materials·2023
Same author

T cell-loaded injectable chitosan scaffold shows short-term efficacy in localised cancer immunotherapy in mice.

Biomaterials science·2023
Same journal

HB-EGF enhances collective cell migration via spatial coordination of traction.

APL bioengineering·2026
Same journal

A pump-free microfluidic device for integrated multi-functional testing of tumor spheroids.

APL bioengineering·2026
Same journal

Photobiomodulation outperforms ultrasound in reducing IL-1 <b><i>β</i></b> -driven chondrocyte inflammation.

APL bioengineering·2026
Same journal

Research progress of 3D-printed anti-infective bone tissue engineering scaffolds based on triply periodic minimal surface structures.

APL bioengineering·2026
Same journal

Biomolecular and cellular chirality: Novel diagnostic perspectives for diseases.

APL bioengineering·2026
Same journal

Platelet membrane-coated nanoparticles: Bioengineering principles, quality control, and translational opportunities.

APL bioengineering·2026
See all related articles

Related Experiment Video

Updated: Aug 16, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.7K

Biomaterials for enhanced immunotherapy.

Nicholas Cunningham, Réjean Lapointe, Sophie Lerouge

    APL Bioengineering
    |December 23, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Biomaterials enhance cancer immunotherapies by improving drug delivery, cancer vaccines, and immune cell delivery. This approach addresses limitations like poor treatment persistence and side effects for better cancer treatment outcomes.

    More Related Videos

    Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
    07:20

    Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

    Published on: January 14, 2011

    14.8K
    Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
    10:16

    Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

    Published on: October 12, 2018

    8.1K

    Related Experiment Videos

    Last Updated: Aug 16, 2025

    Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
    09:28

    Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

    Published on: November 17, 2018

    11.7K
    Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
    07:20

    Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

    Published on: January 14, 2011

    14.8K
    Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
    10:16

    Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

    Published on: October 12, 2018

    8.1K

    Area of Science:

    • Biomedical Engineering
    • Immunology
    • Oncology

    Background:

    • Cancer immunotherapies have transformed cancer treatment, showing superior results compared to traditional methods.
    • Limitations such as insufficient treatment persistence and adverse side effects hinder the full potential of current immunotherapies.
    • Biomaterials present a promising strategy to overcome these challenges in cancer treatment.

    Purpose of the Study:

    • To review recent advancements in biomaterials for cancer immunotherapy.
    • To highlight the role of biomaterials in drug delivery, cancer vaccines, and immune cell delivery.
    • To focus on the application of biomaterials in enhancing immune cell delivery for cancer therapy.

    Main Methods:

    • Literature review of recent studies on biomaterials in cancer immunotherapy.
    • Analysis of biomaterial applications in drug delivery systems for cancer treatment.
    • Examination of biomaterial-based cancer vaccines and immune cell delivery strategies.

    Main Results:

    • Biomaterials enable precise concentration, localization, and controlled release of therapeutic agents.
    • Recent advances show significant improvements in the efficacy of biomaterial-based cancer vaccines.
    • Biomaterials are increasingly utilized for effective immune cell delivery in cancer immunotherapy.

    Conclusions:

    • Biomaterials offer significant advantages for improving cancer immunotherapy efficacy.
    • Controlled delivery of drugs, antigens, and cells via biomaterials addresses key treatment limitations.
    • Further research into biomaterial applications holds great promise for advancing cancer treatment.